Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously immunized against HBV;Reactivation virale B apres greffe de moelle allogenique chez un malade precedemment gueri d'une hepatite virale B

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 6-7, 1999, Pages 770-774

  Romand, François ^a,d   Michallet, Mauricette ^b   Pichoud, Christian ^c   Trepo, Christian ^a,c   Zoulim, Fabien ^a,c  

^a HÔTEL DIEU   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c INSERM   (France)

^d Service de Medecine Interne   (France)

Author keywords

Allogenic bone marrow transplantation; Hepatitis B virus; Immunodepression; Reactivation

Indexed keywords

HEPATITIS VACCINE; ANTIVIRUS AGENT; GANCICLOVIR; HEPATITIS B ANTIBODY;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; REMISSION; VIRUS REACTIVATION; VIRUS REPLICATION; BLOOD; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; MALE; RECURRENT DISEASE; VIROLOGY; VIRUS ACTIVATION;

ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; GANCICLOVIR; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; IMMUNITY, NATURAL; LEUKEMIA, MYELOID, CHRONIC; MALE; RECURRENCE; VIRUS ACTIVATION;

EID: 0033141665     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hanson CA, Sutherland DE, Snover DC. Fulminant hepatic failure in an HBs Ag carrier renal transplant patient following cessation of immunosuppressive therapy. Transplantation 1985;39:311-2.
2. Busuttil DP, Chasty RC, Fraser M, Copplestone JA, Prentice AG. Delayed reactivation of hepatitis B infection after cladribine. Lancet 1996;348:129.
3. Soh LT, Ang PT, Sng I, Chua EJ, Ong YW. Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy. Eur J Cancer 1992;28:1338-9.
4. Pinto P, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindarajan S. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990;65: 878-84.
5. Pariente EA, Goudeau A, Dubois F, Degott C, Gluckman E, Devergie A, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988;33:1185-91.
6. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients'recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2, 10:1104-8.
7. Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, et al. Hepatitis B virus DNA in peripheral blood mononuclear cells in chronic hepatitis B after HBs Ag clearance. Hepatology 1992;16:36-41.
8. Yoffe B, Burns DK, Bhatt HS, Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology 1990;12:187-92.
9. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993;342:1335-40.
10. Hadchouel M, Pasquinelli C, Fournier JG, Hugon RN, Scotto J, Bernard O, et al. Detection of mononuclear cells expressing hepatitis B virus in peripheral blood from HBs Ag positive and negative patients by in situ hybridisation. J Med Virol 1988;24: 27-32.
11. Brécnot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-6.
12. Blum HE, Offensperger WB, Walter E, Offensperger S, Gerok W. Latent hepatitis B virus infection with full-lenght viral genome in a patient serologically immune to hepatitis B virus infection. Liver 1988;8:307-16.
13. Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991;100:1432-4.
14. Thiers V, Nakajima V, Kremsdorf D, Mack D, Schellekens H, Driss F, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988;2:1273-6.
15. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, et al. « Occult »hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-6.
16. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, et al. Hepatitis B virus and apparent fulminant non-A non-B hepatitis. Lancet 1992;339:952-5.
17. Zoulim F, Li J, Baginski I, Lamelin JP, Trépo C. L'amplification enzymatique de séquences d'acides nucléiques viraux. Une révolution méthodologique riche de perspectives en hépatologie. Gastroenterol Clin Biol 1992;16:443-53.
18. Zoulim F, Vitvitski L, Bouffard P, Pichoud C, Rougier P, Lamelin JP, et al. Detection of pre-S1 proteins in peripheral blood mononuclear cells from patients with HBV infection. J Hepatol 1991;12:150-6.
19. Zoulim F, Lamelin JP, Trépo C. Implications cliniques des interactions entre le virus de l'hépatite B et les leucocytes mononucléés. Gastroenterol Clin Biol 1990;14:255-62.
20. Theilmann L, Arnold J, Tox U, Datsis K, Otto G, Hofmann W, et al. Liver transplantation and de novo hepatitis B infection. Lancet 1994;343:677-8.
21. Barin F, Pic P, Dubois F, Roingeard P, Pengloan J, Goudeau A. Réactivation du virus de l'hépatite B (VHB) chez l'immunodéprimé : illustration de la persistance du VHB. Virologie 1997;1:67-68.
22. Grumayer E, Panzer S, Ferenci P, Gadner H. Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. J Hepatol 1989;8:232-5.
23. Liang RH, Lok AS, Lai CL, Chan TK, Todd D, Chiu EK. Hepatitis B infection in patients with lymphomas. Hematol Oncol 1990;8: 261-70.
24. Martin BA, Rowe JM, Kouides PA, DiPersio JF. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant 1995;15:145-8.
25. Locasciulli A, Bacigalupo A, Van Lint MT, Chemello L, Pontisso P, Occhini D, et al. Hepatitis B virus infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant 1990;6:25-9.
26. Webster A, Brenner MK, Prentice HG, Griffiths PD. Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transplant 1989;4:207-8.
27. Chen PM, Fan S, Liu CJ, Hsieh RK, Liu JH, Chuang MW, et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990;49:708-13.
28. Picardi M, Selleri C, De Rosa G, Raiola A, Pezullo L, Rotolo B. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;21:1267-9.
29. Vento S, Di Perri G, Luzzati R, Cruciani M, Garofano T, Mengoli C, et al. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet 1989;1:332-3.
30. Waite J, Gilson RJ, Weller IV, Lacey CJ, Hambling MH, Hawkins A, et al. Hepatitis B virus reactivation or reinfection associated with HIV-1 infection. AIDS 1988;2:443-8.
31. Bouslama K, Knani L, Cabane J, Picard O, Lebas J, Poupon R, et al. Réactivation d'une hépatite B chez un patient anti-HBs positif au cours d'une co-infection par le VIH. Ann Med Interne 1991;142:63-4.
32. Vandercam B, Cornu C, Gala JL, Geubel A, Cahill M, Lamy ME. Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis 1990;9:701-2.
33. Lazizi Y, Grangeot-Keros L, Delfraissy JF, Boue F, Dubreuil P, Badur S, et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus 1. J Infect Dis 1988;158:666-7.
34. Locasciulli A, Bacigalupo A, Alberti A, Van Lint MT, Uderzo C, Marmont AM, et al. Predictability before transplant of hepatic complications following allogeneic bone marrow transplantation. Transplantation 1989;48:68-72.
35. Mc Donald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984;4:116-22.
36. Nagler A, Ilan Y, Adler R, Or R, Naparstek E, Shouval D, et al. Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transplant 1995;15:475-8.
37. Irinondo A, Pastor JM, Hermosa V, Bello C, Gandarillas MA, Richard C, et al. Protection against hepatitis B after marrow transplantation. Ann Intern Med 1986;105:293-4.
38. Zoulim F, Trépo C. Drug therapy of chronic hepatitis B: antiviral efficacy and impact of HBV polymerase gene mutations on the outcome of antiviral therapy (review). J Hepatol 1998;29:151-68.
39. Dumortier J, Durupt S, Chevallier M, Trépo C, Zoulim F. Evolution favorable d'une réactivation du virus de l'hépatite B avec insuffisance hépatocellulaire grâce à un traitement associant corticoïdes, foscarnet et ganciclovir. Gastroenterol Clin Biol 1997;21:982-6.